Skip Nav Destination
Issues
Mechanism of action of a suppressor-activating factor (SAF) produced by a human T cell line
J Immunol (1985) 135 (3): 2228.
Immune responses during human Schistosomiasis mansoni. XI. Immunologic status of patients with acute infections and after treatment.
J Immunol (1985) 135 (3): 2121–2127.
Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
J Immunol (1985) 135 (3): 1714–1718.
T cell regulation of light chain expression: preferential enhancement of Ig kappa production by T cells in the response to DNP.
J Immunol (1985) 135 (3): 1577–1581.
Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2).
J Immunol (1985) 135 (3): 2033–2039.
Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.
J Immunol (1985) 135 (3): 2192–2198.
Structure and expression of two porcine genomic clones encoding class I MHC antigens.
J Immunol (1985) 135 (3): 2167–2175.
Isolation and characterization of novel suppressor T cell clones from murine fetal thymus.
J Immunol (1985) 135 (3): 1582–1588.
The major histocompatibility complex-restricted antigen receptor on T cells: the genetics of expression of an allotype.
J Immunol (1985) 135 (3): 2176–2182.
Failure of PFC inhibition assays to distinguish idiotypically between clonotypes that are readily distinguishable by RIA analysis.
J Immunol (1985) 135 (3): 1683–1689.
Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens.
J Immunol (1985) 135 (3): 1610–1615.
TNP-specific Lyt-2+ cytolytic T cell clones preferentially respond to TNP-conjugated epidermal cells.
J Immunol (1985) 135 (3): 1558–1563.
Effects of various inhibitors of arachidonic acid oxygenation on macrophage superoxide release and tumoricidal activity.
J Immunol (1985) 135 (3): 2040–2044.
Antiproliferative monoclonal antibodies: detection and initial characterization.
J Immunol (1985) 135 (3): 1987–1997.
Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.
J Immunol (1985) 135 (3): 2015–2019.
Carbohydrate determinants associated with carcinoembryonic antigen (CEA).
J Immunol (1985) 135 (3): 1911–1913.
Molecular events in B cell activation. I. Signals required to stimulate G0 to G1 transition of resting B lymphocytes.
J Immunol (1985) 135 (3): 1674–1682.
Mechanism of accessory cell requirement in inducing IL 2 responsiveness by human T4 lymphocytes that generate colonies under PHA stimulation.
J Immunol (1985) 135 (3): 1813–1818.
Human T cell antigen expression during the early stages of fetal thymic maturation.
J Immunol (1985) 135 (3): 1752–1759.
Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice.
J Immunol (1985) 135 (3): 1698–1701.
Functional integrity of cytokineplasts: specific chemotactic and capping responses.
J Immunol (1985) 135 (3): 2090–2094.
cAMP is an essential signal in the induction of antibody production by B cells but inhibits helper function of T cells.
J Immunol (1985) 135 (3): 2084–2089.
Interaction of alpha 1 with alpha 2 region in class I MHC proteins contributes determinants recognized by antibodies and cytotoxic T cells.
J Immunol (1985) 135 (3): 2160–2166.
Analysis of idiotope variability as a function of distance from the binding site for anti-streptococcal group A carbohydrate antibodies.
J Immunol (1985) 135 (3): 1914–1921.
Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells.
J Immunol (1985) 135 (3): 2140–2144.
Induction of antibody responses to influenza virus in human lymphocyte cultures. I. Role of interleukin 2.
J Immunol (1985) 135 (3): 2128–2133.
Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice.
J Immunol (1985) 135 (3): 2108–2114.
T cell locomotion in the tumor microenvironment. I. A collagen-matrix assay.
J Immunol (1985) 135 (3): 2220–2227.
Biosynthesis and maturation of the Lyt-2/3 molecular complex in mouse thymocytes.
J Immunol (1985) 135 (3): 1937–1944.
Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases.
J Immunol (1985) 135 (3): 1786–1791.
Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells.
J Immunol (1985) 135 (3): 1746–1751.
Isolation and characterization of the cDNA clone and genomic clones of a new HLA class II antigen heavy chain, DO alpha.
J Immunol (1985) 135 (3): 2156–2159.
HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant.
J Immunol (1985) 135 (3): 2149–2155.
Influence of antibody isotype on passive serotherapy of lymphoma.
J Immunol (1985) 135 (3): 2183–2186.
Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen.
J Immunol (1985) 135 (3): 1922–1928.
Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens.
J Immunol (1985) 135 (3): 1739–1745.
Interleukin 2 receptor dysfunction in mice undergoing a graft-vs-host reaction.
J Immunol (1985) 135 (3): 1846–1850.
Characterization and partial purification of a specific interleukin 2 inhibitor.
J Immunol (1985) 135 (3): 1834–1839.
Influence of accessory cell and T cell surface antigens on mitogen-induced IL 2 receptor expression.
J Immunol (1985) 135 (3): 1826–1833.
Structural requirements of immunoglobulin G for binding to the Fc gamma receptors of the human tumor cell lines U937, HL-60, ML-1, and K562.
J Immunol (1985) 135 (3): 1975–1980.
The distribution of the Qa-2 alloantigen on functional T lymphocytes.
J Immunol (1985) 135 (3): 1632–1636.
Mechanism of priming of human neutrophils by a soluble lymphoblastoid cell factor.
J Immunol (1985) 135 (3): 2074–2083.
Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products.
J Immunol (1985) 135 (3): 2052–2056.
A histamine-releasing factor from activated human mononuclear cells.
J Immunol (1985) 135 (3): 2027–2032.
Association between the Ro and La antigenic determinants: immunodiffusion analysis of human spleen extract.
J Immunol (1985) 135 (3): 1707–1713.
Longitudinal assessment of immunologic abnormalities of mice with the autosomal recessive mutation, "wasted".
J Immunol (1985) 135 (3): 1806–1812.
Immune response to nucleic acid antigens and native DNA by human peripheral blood lymphocytes in vitro.
J Immunol (1985) 135 (3): 1772–1777.
Humoral factors in very young NZB mice that enhance the maturation of normal B cell precursors. Partial purification and characterization.
J Immunol (1985) 135 (3): 1891–1899.
Influenza-specific suppression: contribution of major viral proteins to the generation and function of T suppressor cells.
J Immunol (1985) 135 (3): 2134–2139.
Interleukins 2 and 3 regulate the in vitro proliferation of two distinguishable populations of 20-alpha-hydroxysteroid dehydrogenase-positive cells.
J Immunol (1985) 135 (3): 1864–1871.
T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.
J Immunol (1985) 135 (3): 1624–1631.
Defining cytolytic T lymphocyte recognition of chemically modified self. I. Response to trinitrophenyl-H-2Kk.
J Immunol (1985) 135 (3): 1564–1572.
Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).
J Immunol (1985) 135 (3): 2063–2068.
Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
G D Ross; W J Yount; M J Walport; J B Winfield; C J Parker; C R Fuller; R P Taylor; B L Myones; P J Lachmann
J Immunol (1985) 135 (3): 2005–2014.
Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.
J Immunol (1985) 135 (3): 2069–2073.
Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
J Immunol (1985) 135 (3): 1731–1738.
Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
J Immunol (1985) 135 (3): 1719–1723.
Molecular associations of class II MHC antigens in mitogen-stimulated B cells.
J Immunol (1985) 135 (3): 1668–1673.
Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression.
J Immunol (1985) 135 (3): 1819–1825.
Genetic and biological characterization of a T suppressor cell induced by anti-idiotypic antibody.
J Immunol (1985) 135 (3): 1589–1597.
5-Azacytidine treatment of a murine cytotoxic T cell line alters interferon-gamma gene induction by interleukin 2.
J Immunol (1985) 135 (3): 1551–1554.
Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production
J Immunol (1985) 135 (3): 2228.
Tolerance to azobenzenearsonate: idiotype-specific suppression, B cell dominance, and clonal elimination
J Immunol (1985) 135 (3): 2228.
Characterization of circulating and cutaneous IgA immune complexes in patients with dermatitis herpetiformis.
J Immunol (1985) 135 (3): 1760–1765.
Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages.
J Immunol (1985) 135 (3): 1857–1863.
Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2.
J Immunol (1985) 135 (3): 1851–1856.
Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.
J Immunol (1985) 135 (3): 1900–1905.
Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1.
J Immunol (1985) 135 (3): 1872–1877.
Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23.
J Immunol (1985) 135 (3): 1929–1936.
Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice.
J Immunol (1985) 135 (3): 1702–1706.
Clonal analysis of B cell growth and differentiation activities induced from T lymphocytes upon triggering of T3-Ti and T11 pathways.
J Immunol (1985) 135 (3): 1884–1890.
Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
J Immunol (1985) 135 (3): 1644–1651.
Preferential generation of human T cell hybrids with a tetraploid fusion partner.
J Immunol (1985) 135 (3): 1792–1799.
Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation.
J Immunol (1985) 135 (3): 1766–1771.
Strong suppression by monocytes of T cell mitogenesis in chicken peripheral blood leukocytes.
J Immunol (1985) 135 (3): 1652–1660.
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Advertisement
Advertisement